NIH-funded study suggests PrEP therapy, approved for adults, is safe for youth
Bethesda, Maryland–(ENEWSPF)–September 5, 2017. A National Institutes of Health network study has confirmed that a combination of two drugs taken daily to reduce the chances of HIV infection among high-risk adults also works well and appears safe in males ages 15 to 17 years.
Truvada, a single pill containing the drugs tenofovir and emtricitabine (TDF/FTC), is currently approved for daily use…
